BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, Taylor LS, Kumar S, Tony Zhou Q. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm Sin B 2021;11:2505-36. [PMID: 34522596 DOI: 10.1016/j.apsb.2021.05.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 58] [Article Influence: 49.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao P, Han W, Shu Y, Li M, Sun Y, Sui X, Liu B, Tian B, Liu Y, Fu Q. Liquid–liquid phase separation drug aggregate: Merit for oral delivery of amorphous solid dispersions. Journal of Controlled Release 2023;353:42-50. [DOI: 10.1016/j.jconrel.2022.11.033] [Reference Citation Analysis]
2 Pöstges F, Kayser K, Stoyanov E, Wagner KG. Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1:1) and hydroxypropyl cellulose in ternary amorphous solid dispersions. International Journal of Pharmaceutics: X 2022;4:100115. [DOI: 10.1016/j.ijpx.2022.100115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Winck J, Daalmann M, Berghaus A, Thommes M. In-line Monitoring of Solid Dispersion Preparation in Small Scale Extrusion based on UV-Vis Spectroscopy. Pharmaceutical Development and Technology 2022. [DOI: 10.1080/10837450.2022.2144887] [Reference Citation Analysis]
4 Aldeeb RA, El-miligi MF, El-nabarawi M, Tag R, Amin HMS, Taha AA. Enhancement of the Solubility and Dissolution Rate of Telmisartan by Surface Solid Dispersions Employing Superdisintegrants, Hydrophilic Polymers and Combined Carriers. Sci Pharm 2022;90:71. [DOI: 10.3390/scipharm90040071] [Reference Citation Analysis]
5 Dain IA, Zolotov SA, Demina NB, Zolotova AS, Buzanov GA, Retivov VM, Ponomaryov YS. Complex dispersions of poloxamers and mesoporous carriers with ibrutinib. OpenNano 2022;8:100073. [DOI: 10.1016/j.onano.2022.100073] [Reference Citation Analysis]
6 Stegemann S, Moreton C, Svanbäck S, Box K, Motte G, Paudel A. Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.103344] [Reference Citation Analysis]
7 Wang B, Wang X, Zhu Y, Yin T, Gou J, Wang Y, He H, Zhang Y, Tang X. Characterization of nimodipine amorphous nanopowder prepared by quenching cooling combined with wet milling and spray drying. International Journal of Pharmaceutics 2022;628:122332. [DOI: 10.1016/j.ijpharm.2022.122332] [Reference Citation Analysis]
8 Schikarski T, Trzenschiok H, Avila M, Peukert W. Impact of solvent properties on the precipitation of active pharmaceutical ingredients. Powder Technology 2022. [DOI: 10.1016/j.powtec.2022.118032] [Reference Citation Analysis]
9 Kang S, Chen AB, Yu T, Yang Y, Gui H, Liu J, Chen D. A new spray current control for the reliable operation of a single-capillary electrospray. Journal of Aerosol Science 2022;166:106073. [DOI: 10.1016/j.jaerosci.2022.106073] [Reference Citation Analysis]
10 Malkawi R, Malkawi WI, Al-Mahmoud Y, Tawalbeh J. Current Trends on Solid Dispersions: Past, Present, and Future. Adv Pharmacol Pharm Sci 2022;2022:5916013. [PMID: 36317015 DOI: 10.1155/2022/5916013] [Reference Citation Analysis]
11 Tambe S, Jain D, Meruva SK, Rongala G, Juluri A, Nihalani G, Mamidi HK, Nukala PK, Bolla PK. Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization. Pharmaceutics 2022;14:2203. [PMID: 36297638 DOI: 10.3390/pharmaceutics14102203] [Reference Citation Analysis]
12 Hermeling M, Nueboldt C, Heumann R, Hoheisel W, Breitkreutz J. Nano-Dry-Melting: A Novel Technology for Manufacturing of Pharmaceutical Amorphous Solid Dispersions. Pharmaceutics 2022;14:2145. [PMID: 36297580 DOI: 10.3390/pharmaceutics14102145] [Reference Citation Analysis]
13 Palle Holm T, Kokott M, Manne Knopp M, Boyd BJ, Berthelsen R, Quodbach J, Löbmann K. Development of a multiparticulate drug delivery system for in situ amorphisation. Eur J Pharm Biopharm 2022:S0939-6411(22)00216-8. [PMID: 36191869 DOI: 10.1016/j.ejpb.2022.09.021] [Reference Citation Analysis]
14 Frank DS, Nie H, Chandra A, Coelho A, Dalton C, Dvorak H, Elkhabaz A, Fahy M, Ormes J, Parker A, Punia A, Rowe J, Schenck L, Smith D, Strotman NA, Wang M, Wareham L. High Bulk-Density Amorphous Dispersions to Enable Direct Compression of Reduced Tablet Size Amorphous Dosage Units. J Pharm Sci 2022:S0022-3549(22)00409-9. [PMID: 36115592 DOI: 10.1016/j.xphs.2022.09.007] [Reference Citation Analysis]
15 Liu K, Liu W, Dong Z, Zhang L, Li Q, Zhang R, He H, Lu Y, Wu W, Qi J. Translation of ionic liquids to be enteric nanoparticles for facilitating oral absorption of cyclosporine A. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10405] [Reference Citation Analysis]
16 Wang Y, Wang W, Yu E, Zhuang W, Sun X, Wang H, Li Q. Preparation of a camptothecin analog FLQY2 self-micelle solid dispersion with improved solubility and bioavailability. J Nanobiotechnology 2022;20:402. [PMID: 36064403 DOI: 10.1186/s12951-022-01596-2] [Reference Citation Analysis]
17 Diogo HP, Ramos JJM. Molecular mobility in Soluplus, a polymer with extremely low dynamic fragility; A study by thermally stimulated depolarization currents. Journal of Non-Crystalline Solids 2022;591:121738. [DOI: 10.1016/j.jnoncrysol.2022.121738] [Reference Citation Analysis]
18 Barbero-colmenar E, Guastaferro M, Baldino L, Cardea S, Reverchon E. Supercritical CO2 Assisted Electrospray to Produce Poly(lactic-co-glycolic Acid) Nanoparticles. ChemEngineering 2022;6:66. [DOI: 10.3390/chemengineering6050066] [Reference Citation Analysis]
19 Pugliese A, Tobyn M, Hawarden LE, Abraham A, Blanc F. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance. Mol Pharm 2022. [PMID: 36037249 DOI: 10.1021/acs.molpharmaceut.2c00479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Rangaraj N, Sampathi S, Junnuthula V, Kolimi P, Mandati P, Narala S, Nyavanandi D, Dyawanapelly S. Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects. Pharmaceutics 2022;14:1807. [DOI: 10.3390/pharmaceutics14091807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 El-Gendy N, Bertha CM, Abd El-Shafy M, Gaglani DK, Babiskin A, Bielski E, Boc S, Dhapare S, Fang L, Feibus K, Kaviratna A, Li BV, Luke MC, Ma T, Newman B, Spagnola M, Walenga RL, Zhao L. Scientific and regulatory activities initiated by the U.S. Food and Drug Administration to foster approvals of generic dry powder inhalers: quality perspective. Adv Drug Deliv Rev 2022;:114519. [PMID: 36038083 DOI: 10.1016/j.addr.2022.114519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ajjarapu S, Banda S, Basim P, Dudhipala N. Melt Fusion Techniques for Solubility Enhancement: A Comparison of Hot Melt Extrusion and KinetiSol® Technologies. Sci Pharm 2022;90:51. [DOI: 10.3390/scipharm90030051] [Reference Citation Analysis]
23 Shi Q, Chen H, Wang Y, Wang R, Xu J, Zhang C. Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance. Pharmaceutics 2022;14:1747. [PMID: 36015373 DOI: 10.3390/pharmaceutics14081747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Palle Holm T, Manne Knopp M, Berthelsen R, Löbmann K. Supersaturated amorphous solid dispersions of celecoxib prepared by in situ microwave irradiation. Int J Pharm 2022;:122115. [PMID: 35985526 DOI: 10.1016/j.ijpharm.2022.122115] [Reference Citation Analysis]
25 Mukesh S, Mukherjee G, Singh R, Steenbuck N, Demidova C, Joshi P, Sangamwar AT, Wade RC. Comparative analysis of drug-salt-polymer interactions by experiment and molecular simulation improves biopharmaceutical performance.. [DOI: 10.1101/2022.08.11.503409] [Reference Citation Analysis]
26 Heczko D, Hachuła B, Maksym P, Kamiński K, Zięba A, Orszulak L, Paluch M, Kamińska E. The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide. Pharmaceuticals (Basel) 2022;15:971. [PMID: 36015118 DOI: 10.3390/ph15080971] [Reference Citation Analysis]
27 Dangre PV, Shinde SB, Surana SJ, Jain PG, Chalikwar SS. Development and exploration on flowability of solid self-nanoemulsifying drug delivery system of morin hydrate. Advanced Powder Technology 2022;33:103716. [DOI: 10.1016/j.apt.2022.103716] [Reference Citation Analysis]
28 Yan T, Wang H, Song X, Yan T, Ding Y, Luo K, Zhen J, He G, Nian L, Wang S, Wang Z. Fabrication of apigenin nanoparticles using antisolvent crystallization technology: A comparison of supercritical antisolvent, ultrasonic-assisted liquid antisolvent, and high-pressure homogenization technologies. International Journal of Pharmaceutics 2022;624:121981. [DOI: 10.1016/j.ijpharm.2022.121981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Newman A, Zografi G. Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tejada Jacob G, Passamai VE, Katz S, Castro GR, Alvarez V. Hydrogels for extrusion-based bioprinting: General considerations. Bioprinting 2022;27:e00212. [DOI: 10.1016/j.bprint.2022.e00212] [Reference Citation Analysis]
31 Zhang J, Liu M, Zeng Z. The antisolvent coprecipitation method for enhanced bioavailability of poorly water-soluble drugs. Int J Pharm 2022;:122043. [PMID: 35902056 DOI: 10.1016/j.ijpharm.2022.122043] [Reference Citation Analysis]
32 Liu W, Zhang L, Dong Z, Liu K, He H, Lu Y, Wu W, Qi J. Rod-like mesoporous silica nanoparticles facilitate oral drug delivery via enhanced permeation and retention effect in mucus. Nano Res . [DOI: 10.1007/s12274-022-4601-2] [Reference Citation Analysis]
33 Heng W, He X, Song Y, Han J, Pang Z, Qian S, Zhang J, Gao Y, Wei Y. Insights into Cocrystallization and Coamorphization Engineering Techniques in the Delivery of Traditional Chinese Medicine: Formation Mechanism, Solid-State Characterization, and Improved Pharmaceutical Properties. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.1c01352] [Reference Citation Analysis]
34 Li J, Duggirala NK, Kumar NSK, Su Y, Suryanarayanan R. Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations. Mol Pharm 2022. [PMID: 35797094 DOI: 10.1021/acs.molpharmaceut.2c00307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mishra SM, Richter M, Mejia L, Sauer A. Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach. Pharmaceutics 2022;14:1429. [DOI: 10.3390/pharmaceutics14071429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kayser K, Monschke M, Wagner KG. ASD Formation Prior to Material Characterization as Key Parameter for Accurate Measurements and Subsequent Process Simulation for Hot-Melt Extrusion. AAPS PharmSciTech 2022;23:176. [PMID: 35750968 DOI: 10.1208/s12249-022-02331-8] [Reference Citation Analysis]
37 Phyo P, Xu W, Frank D, Li T, Su Y. Probing Molecular Packing of Drug Substances in Nanometer Domains in Pharmaceutical Formulations Using 19 F Magic Angle Spinning NMR. J Phys Chem C. [DOI: 10.1021/acs.jpcc.2c01871] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Jia W, Yawman PD, Pandya KM, Sluga K, Ng T, Kou D, Nagapudi K, Luner PE, Zhu A, Zhang S, Hou HH. Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions Via Noninvasive Imaging Analytics and Material Characterization. Pharm Res 2022. [PMID: 35661085 DOI: 10.1007/s11095-022-03308-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Patel K, Shah S, Patel J. Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review. DARU J Pharm Sci 2022;30:165-189. [DOI: 10.1007/s40199-022-00440-0] [Reference Citation Analysis]
40 Zolotov SA, Demina NB, Ponomarev ES, Dain IA, Zolotova AS. Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances. Razrabotka i registraciâ lekarstvennyh sredstv 2022;11:87-93. [DOI: 10.33380/2305-2066-2022-11-2-87-93] [Reference Citation Analysis]
41 Mathers A, Pechar M, Hassouna F, Fulem M. API solubility in semi-crystalline polymer: Kinetic and thermodynamic phase behavior of PVA-based solid dispersions. Int J Pharm 2022;623:121855. [PMID: 35623485 DOI: 10.1016/j.ijpharm.2022.121855] [Reference Citation Analysis]
42 Kolev I, Ivanova N, Topouzova-Hristova T, Dimova T, Koseva P, Vasileva I, Ivanova S, Apostolov A, Alexieva G, Tzonev A, Strashilov V. Ammonio Methacrylate Copolymer (Type B)-Diltiazem Interactions in Solid Dispersions and Microsponge Drug-Delivery Systems. Polymers (Basel) 2022;14:2125. [PMID: 35632008 DOI: 10.3390/polym14102125] [Reference Citation Analysis]
43 Lu M, Wei W, Xu W, Polyakov NE, Dushkin AV, Su W. Preparation of DNC Solid Dispersion by a Mechanochemical Method with Glycyrrhizic Acid and Polyvinylpyrrolidone to Enhance Bioavailability and Activity. Polymers (Basel) 2022;14:2037. [PMID: 35631919 DOI: 10.3390/polym14102037] [Reference Citation Analysis]
44 Kyeremateng SO, Voges K, Dohrn S, Sobich E, Lander U, Weber S, Gessner D, Evans RC, Degenhardt M. A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development. Pharmaceutics 2022;14:1044. [DOI: 10.3390/pharmaceutics14051044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lim LM, Park J, Hadinoto K. Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug–Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug. Pharmaceutics 2022;14:979. [DOI: 10.3390/pharmaceutics14050979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Du Y, Su Y. 19F Solid-state NMR characterization of pharmaceutical solids. Solid State Nuclear Magnetic Resonance 2022. [DOI: 10.1016/j.ssnmr.2022.101796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Schönfeld BV, Westedt U, Wagner KG. Compression Modulus and Apparent Density of Polymeric Excipients during Compression—Impact on Tabletability. Pharmaceutics 2022;14:913. [DOI: 10.3390/pharmaceutics14050913] [Reference Citation Analysis]
48 Van Duong T, Thuy Nguyen H, Taylor LS. Combining enabling formulation strategies to generate supersaturated solutions of delamanid: in situ salt formation during amorphous solid dispersion fabrication for more robust release profiles. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Meola TR, Bremmell KE, Williams DB, Schultz HB, Prestidge CA. Bio-enabling strategies to mitigate the pharmaceutical food effect: a mini review. Int J Pharm 2022;:121695. [PMID: 35339633 DOI: 10.1016/j.ijpharm.2022.121695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
50 Yang X, Lu W, Wang M, De La Cruz LK, Tan C, Wang B. Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill. Int J Pharm 2022;618:121650. [PMID: 35276229 DOI: 10.1016/j.ijpharm.2022.121650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Huang F, Jiang X, Sallam MA, Zhang X, He W. A Nanocrystal Platform Based on Metal-Phenolic Network Wrapping for Drug Solubilization. AAPS PharmSciTech 2022;23:76. [PMID: 35178657 DOI: 10.1208/s12249-022-02220-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Thompson SA, Davis DA Jr, Moon C, Williams RO 3rd. Increasing Drug Loading of Weakly Acidic Telmisartan in Amorphous Solid Dispersions through pH Modification during Hot-Melt Extrusion. Mol Pharm 2022;19:318-31. [PMID: 34846902 DOI: 10.1021/acs.molpharmaceut.1c00805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Kaewkroek K, Petchsomrit A, Wira Septama A, Wiwattanapatapee R. Development of starch/chitosan expandable films as a gastroretentive carrier for ginger extract-loaded solid dispersion. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2021.12.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Anane-Adjei AB, Jacobs E, Nash SC, Askin S, Soundararajan R, Kyobula M, Booth J, Campbell A. Amorphous Solid Dispersions: Utilization and Challenges in Preclinical Drug Development within AstraZeneca. Int J Pharm 2021;:121387. [PMID: 34933082 DOI: 10.1016/j.ijpharm.2021.121387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
55 Sansare S, Aziz H, Sen K, Patel S, Chaudhuri B. Computational Modeling of Fluidized Beds with a Focus on Pharmaceutical Applications: A Review. J Pharm Sci 2021:S0022-3549(21)00489-5. [PMID: 34555391 DOI: 10.1016/j.xphs.2021.09.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lv Y, He W, Wu W. Editorial of Special Issue of Hot Topic Reviews in Drug Delivery. Acta Pharm Sin B 2021;11:2094-5. [PMID: 34522578 DOI: 10.1016/j.apsb.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]